99mTc-rBitistatin

N/A

Report date: 2025/11/24 11:49:09

NME

Base Information

Drug Name99mTc-rBitistatin

Drug Alias NameN/A

ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[5]

Mechanisms of ActionIntegrin alpha-IIb/beta-3 antagonists

TargetsIntegrin alpha-IIb/beta-3

Therapy Area/IndicationsVenous Thrombosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesTemple University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTemple University

Active IndicationsN/A

Inactive IndicationsVenous Thrombosis

Other Information

ATC CodeN/A